Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Validity and Reliability of Arabic Version of Extended Aberdeen Spine Pain Scale

30 de junio de 2026 actualizado por: Sara Salah Ismaiel Elballat, Cairo University

The goal of this observational study is to determine whether the Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS) is a valid and reliable tool for assessing spine-related pain and functional disability in Arabic-speaking adults with nonspecific spinal pain.

The main questions it aims to answer are:

  • Is the Arabic version of the EASPS a valid instrument for evaluating spine-related pain and disability among Arabic-speaking patients?
  • Is the Arabic version of the EASPS a reliable instrument with acceptable internal consistency and test-retest reliability?

Participants will:

  • Complete the Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS).
  • Complete the Arabic version of the Short Form-36 (SF-36) questionnaire to assess construct validity.
  • Participate in the cultural adaptation and validation process of the Arabic EASPS.
  • A subgroup of participants will complete the Arabic EASPS again after 7 days to assess test-retest reliability.

Descripción general del estudio

Descripción detallada

Spinal pain, including cervical, thoracic, and lumbar pain, is one of the most common musculoskeletal disorders worldwide and is associated with significant disability, reduced quality of life, and increased healthcare utilization. Accurate assessment of spinal pain and its impact on functional activities is essential for clinical decision-making, monitoring treatment outcomes, and conducting research. Patient-reported outcome measures provide a practical and efficient method for evaluating pain severity and disability; however, the availability of culturally adapted and validated assessment tools for Arabic-speaking populations remains limited.

The Extended Aberdeen Spine Pain Scale (EASPS) is a multidimensional self-administered questionnaire designed to assess pain intensity, functional limitations, and disability related to the cervical, thoracic, and lumbar regions of the spine. The instrument has demonstrated acceptable psychometric properties in its original English version and has been culturally adapted into other languages. However, an Arabic version has not yet been developed or validated.

The purpose of this prospective observational study is to translate, culturally adapt, and evaluate the validity and reliability of the Arabic version of the Extended Aberdeen Spine Pain Scale among Arabic-speaking adults with nonspecific spinal pain. The translation and cross-cultural adaptation process will follow internationally accepted guidelines and will include forward translation, reconciliation, backward translation, expert committee review, and cognitive debriefing with representatives of the target population.

A total of 300 Arabic-speaking adults aged 18 to 45 years with nonspecific cervical, thoracic, or lumbar spinal pain will be recruited. Participants will complete the Arabic version of the EASPS and the validated Arabic version of the Short Form-36 (SF-36) Health Survey. Construct validity will be assessed by examining the relationship between EASPS scores and SF-36 outcomes. Face and content validity will be evaluated by expert panels consisting of healthcare professionals and language specialists. Exploratory factor analysis will be conducted to investigate the underlying factor structure of the questionnaire.

Reliability testing will include assessment of internal consistency using Cronbach's alpha coefficient and test-retest reliability using intraclass correlation coefficients (ICC). A subgroup of participants will complete the Arabic EASPS for a second time after a seven-day interval, provided that no significant clinical changes occur during that period.

The findings of this study are expected to provide a culturally appropriate, valid, and reliable Arabic version of the Extended Aberdeen Spine Pain Scale, facilitating the assessment of spinal pain and disability in clinical practice and research settings across Arabic-speaking populations.

Tipo de estudio

De observación

Inscripción (Actual)

300

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Giza, Egipto
        • Cairo University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

The study population will consist of Arabic-speaking adults aged 18 to 45 years diagnosed with nonspecific spinal pain involving the cervical, thoracic, and/or lumbar regions of the spine. Eligible participants will be recruited from outpatient physical therapy and musculoskeletal clinics. Participants must be able to read and understand Arabic and provide informed consent. Individuals with a history of spinal surgery, neurological deficits, serious spinal pathology (e.g., cancer or infection), cognitive impairment, or psychiatric conditions that may interfere with questionnaire completion will be excluded.

Descripción

Inclusion Criteria:

  • Adults aged 18-45 years.
  • Both sexes.
  • Diagnosed with nonspecific spinal pain (cervical, thoracic, or lumbar).
  • Arabic is a primary spoken and written language.
  • Ability to provide informed consent.

Inclusion criteria for experts:

  • Their experiences aren't less than ten years or at least master's degree in physical therapy.
  • Major part of their work is with the Arabic population.
  • They are fluent in Arabic and English language.
  • Both genders were included.

Exclusion Criteria:

  • History of spinal surgery.
  • Neurological deficits or serious pathology (e.g., cancer, infection).
  • Cognitive impairment or psychiatric conditions preventing questionnaire completion.
  • Undergoing active treatment changes during test-retest interval.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Arabic-Speaking Adults with Nonspecific Spinal Pain
This cohort consists of Arabic-speaking adults aged 18 to 45 years diagnosed with nonspecific spinal pain affecting the cervical, thoracic, and/or lumbar regions of the spine. Participants will complete the Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS) and the Arabic version of the SF-36 questionnaire. A subgroup of participants will complete the Arabic EASPS again after 7 days to evaluate test-retest reliability as part of the psychometric validation process.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Arabic Version of the Extended Aberdeen Spine Pain Scale (EASPS)
Periodo de tiempo: Baseline and 7 Days
The Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS) will be used to assess spine-related pain and disability. The questionnaire contains 30 items covering pain, physical impairment, and functional disability. Responses are summed and converted to a score ranging from 0 to 100, with higher scores indicating greater disability. The measure will be used to evaluate the validity and reliability of the Arabic version of the instrument.
Baseline and 7 Days

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Arabic Version of the Short Form-36 Health Survey (SF-36)
Periodo de tiempo: Baseline
The Arabic version of the SF-36 questionnaire will be administered to assess construct validity of the Arabic EASPS. The SF-36 evaluates health-related quality of life across physical and mental health domains. The SF-36 yields domain scores ranging from 0 to 100, with higher scores indicating better health status and functioning. Correlations between SF-36 scores and EASPS scores will be analyzed to determine construct validity.
Baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

15 de septiembre de 2025

Finalización primaria (Actual)

1 de abril de 2026

Finalización del estudio (Actual)

1 de abril de 2026

Fechas de registro del estudio

Enviado por primera vez

22 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

22 de junio de 2026

Publicado por primera vez (Actual)

26 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir